Nicolas Falvo

Oncologist
CHU de Dijon-Bourgogne

Presentation(s):

• PB0917 - The Ottawa Score did not predict recurrent venous thromboembolism in the prospective TROPIQUE cohort study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0930 - Cancer associated thrombosis on bevacizumab: risk of recurrence and bleeding if bevacizumab is stopped or continued

  Monday, July 11, 2022
  6:30 PM – 7:30 PM